Angion Biomedica Corp. Business Finance Contracts & Agreements
16 Contracts & Agreements
- Assignment Agreements (3 contracts)
- Note Agreements (3)
- Registration Rights Agreements (1)
- Stock Agreements (4)
- Underwriting Agreements (2)
- Warrant Agreements (3)
- Note Purchase Agreement, dated January 17, 2023, by and between Elicio Therapeutics, Inc. and Angion Biomedica Corp., and Form of Promissory Note (Filed With SEC on January 17, 2023)
- Stock Purchase Agreement, dated February 4, 2021, by and among Angion Biomedica Corp. and the purchasers named therein (Filed With SEC on February 9, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on February 1, 2021)
- Form of Common Stock Certificate (Filed With SEC on February 1, 2021)
- Form of Underwriting Agreement (Filed With SEC on February 1, 2021)
- Promissory Note and Agreement, dated April 21, 2020, by and between Angion Biomedica Corp. and Hanmi Bank (Filed With SEC on January 15, 2021)
- Registration Rights Agreement, dated as of March 31, 2020, by and among Angion Biomedica Corp. and the investors party thereto (Filed With SEC on January 15, 2021)
- Form of Broker Warrant to Purchase Common Stock (Filed With SEC on January 15, 2021)
- Form of Convertible Promissory Note (Filed With SEC on January 15, 2021)
- Form of Warrant to Purchase Common Stock (Filed With SEC on January 15, 2021)
- Form of Representative’s Warrant Agreement (Filed With SEC on May 23, 2014)
- UNDERWRITING AGREEMENT between ANGION BIOMEDICA CORP. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on May 23, 2014)
- angionbiomedica corporation employment,confidential information and INVENTION ASSIGNMENT AGREEMENT (Filed With SEC on April 14, 2014)
- ANGIONBIOMEDICA CORPORATION EMPLOYMENT,CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENT (Filed With SEC on April 14, 2014)
- ANGION BIOMEDICA CORPORATION EMPLOYEE CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENT (Filed With SEC on April 14, 2014)
- STOCK OPTION CERTIFICATE ThisStock Option is granted by ANGIONBIOMEDICA CORP. to (Filed With SEC on April 14, 2014)
